GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Debt-to-Revenue

BioLASCO Taiwan Co (ROCO:6662) Debt-to-Revenue : 0.31 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BioLASCO Taiwan Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$7.4 Mil. BioLASCO Taiwan Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$50.8 Mil. BioLASCO Taiwan Co's annualized Revenue for the quarter that ended in Mar. 2024 was NT$190.9 Mil. BioLASCO Taiwan Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.30.


BioLASCO Taiwan Co Debt-to-Revenue Historical Data

The historical data trend for BioLASCO Taiwan Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Debt-to-Revenue Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.25 0.30 0.28 0.22

BioLASCO Taiwan Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.21 0.25 0.18 0.31

Competitive Comparison of BioLASCO Taiwan Co's Debt-to-Revenue

For the Biotechnology subindustry, BioLASCO Taiwan Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's Debt-to-Revenue falls into.



BioLASCO Taiwan Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BioLASCO Taiwan Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.773 + 51.433) / 264.723
=0.22

BioLASCO Taiwan Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(7.441 + 50.769) / 190.868
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


BioLASCO Taiwan Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLASCO Taiwan Co (ROCO:6662) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines